Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ.

Far East Super Laboratories Ltd. is a private company headquartered in China that operates testing laboratories.

Bionovo, Inc. operates as a late stage clinical drug discovery and development company focusing on women’s health and cancer primarily in the United States. The company’s drug development process utilizes botanical sources used in traditional Chinese medicine to produce biologically active compounds. Its lead drug candidate is Menerba, a receptor sub-type selective estrogen receptor modulator, which is in Phase III clinical trial for the treatment of vasomotor symptoms of menopause. The company is also developing Bezielle, an oral anti-cancer agent that in Phase II clinical trail for the treatment of advanced breast cancer; and Seala for the treatment of post-menopausal vulvar and vaginal atrophy. Bionovo, Inc. was founded in 2002 and is headquartered in Emeryville, California. On October 26, 2012, Bionovo, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Northern District of California.

West China Second University Hospital is a Chinese private company located in Chengdu. The firm provides women and children healthcare services.

Research Development Foundation is an American private company that operates as noncommercial research organizations.

BL Corp. engages in the development of biopharmaceutical products. The company operates through the following business divisions: Bio-New Treatment and Product. Its products include poly-y-glutamic acid, lactobacillus plantarum BLS41, and skincare products. The company was founded on December 30, 1999 and is headquartered in Yongin-si, South Korea.

Melema Pharma Gmbh is a German private company that operates as a biopharmaceutical company that develops derivatives of natural substances for the immunotherapeutic treatment of cancer.

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of the tissues in the body have receptors for cortisol, and the effects of excess cortisol are severe and often life-threatening. Our initial research has been with mifepristone, which potently blocks the cortisol receptor. On February 17, 2012, the FDA approved Korlym® (mifepristone) in the United States as a once-daily oral medication for treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. Mifepristone is also being studied in a phase 3 trial, evaluating the impact of cortisol blockade on the psychotic features of psychotic depression. We plan to continue enrolling patients in this study throughout 2013.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Hebei Jinyihe Biotechnology Co., Ltd., established on 2020-11-02, Business scope includes general items:biotechnology products,nano biomaterials,Feed and Feed Additives,Sanitation products,food,Biological product,electronic product,medical instruments,Disinfection equipment,Cleaning Products,chemical medicine,Traditional Chinese Medicine and Veterinary Medicine,Chemical Products(Hazardous chemicals and precursor drugs are excluded),Biological Engineering,cosmetic,Technology research and development of beauty equipment,Production,Sales,technical consulting,Technical Services;Sanitation and disinfection technical services;chemical reagent(Excluding hazardous chemicals),hardware products,Instrumentation,office equipment,Wholesale and retail of laboratory equipment;Bioassay Technology Development,technical consulting,technology transfer;Import and export business of various commodities and technologies(Except for national restrictions and prohibitions).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Namomei Technology Co., Ltd., established on 2019-08-14, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Sell ​​self-developed products;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

Beijing Haoer Biotechnology Co., Ltd., established on 2018-03-01, Business scope includes biotechnology development,technical consulting,Technical Services,technology transfer,Technology Promotion;Import and export;Technology Import and Export;Agent import and export;software development;Business Management Consulting,health management(Except for medical treatment activities subject to approval),Health Advisory(Except for medical treatment activities subject to approval);sell cosmetics,Iclass of medical devices.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Sichuan Medical Shun Technology Co., Ltd., established on 2016-07-18, Business scope includes research and development of medical and pharmaceutical technology;Technical Services,technology development,technical consulting,Technology Promotion;Medical Consulting Services(Does not include health care activities);Information Technology Development;Medical Research and Experimental Development;Nutrition and Health Consulting;Computer Information Technology Services;Information system operation and maintenance services;software development;Information system integration service;Artificial intelligence basic resources and technology platform;Artificial intelligence general application system;internet data service;AI Hardware Sales;Retailing of computer software, hardware and auxiliary equipment;Information security equipment sales;Wearable smart device sales;electronics sales;animation design;computer animation design;multi-media design;Radio and television program production(Did not obtain the relevant administrative license(approval),Do not carry out business activities);Planning creative services;translation service;Educational Consulting(Education and training activities that do not include licensing approval);Value-added Telecom Services(Did not obtain the relevant administrative license(approval),Do not carry out business activities);Computer and Office Equipment Repair;computer,communication equipment(Excluding wireless broadcasting and television transmitting and satellite ground receiving equipment)lease;Business Consulting(No Securities,futures,Financial and investment consulting);Technical extension services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Zhongao Biomedical Technology (Guangdong) Co., Ltd., established on 2018-11-15, Business scope includes general items:Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Natural science research and experimental development;R&D and application of cell technology;Domestic trade agent;trade broker;internet sales(Except for products that require a license for sale);Sales of Class I Medical Devices;Wholesale of protective equipment for medical staff;Retailing of protective equipment for healthcare workers;Sales of hygiene products and single-use medical products;Class I Medical Device Leasing;Medical Mask Retail;Import and export agency;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)[The above business scope does not involve human stem cells,Development and application of genetic diagnosis and treatment technology;Steaming of Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines;Research and development of rare and unique precious varieties in China,farming,Planting and production of related propagating material(including farming,animal husbandry,Good Genes of Aquaculture)][The above business scope involves:Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval)](The above projects do not involve special management measures for foreign investment access)

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.